"So far I don't really trust it," Sabalenka
told reporters following her fourth round 6-1 6-2 mugging of
Marketa Vondrousova.
"It's tough to say, but I don't really want it yet and I don't
want my family take it.
"If I will have to do it, then of course I have to do it because
our life is a travel life."
While Sabalenka wants more information about vaccines, the
22-year-old Belarusian is well aware of her next opponent Barty,
who advanced into the last eight with a 6-1 1-6 6-2 win over
Victoria Azarenka.
Of major concern for Sabalenka is how quickly the vaccines were
produced, the number that are now available and which one might
be best for her.
"I have to speak with my doctors and see which one is better for
me," said Sabalenka. "But for now, I don't really trust it.
"They just make it, like really quick and there wasn't enough
time to test it and to see what can happen.
"So I think this is not enough time to make the good one."
Svitolina said she to would wait because at the moment getting
the vaccine makes no sense.
"It will not really help you in many ways because you have to
quarantine anyway because ATP and WTA, they oblige you to
quarantine anyway, like 24 hours as soon as you get it," said
the Ukrainian, who advanced to the quarters with 2-6 7-5 7-5
decision over ninth seeded Czech Petra Kvitova.
"Okay, you will reduce your symptoms if you get it, but still,
there is a chance that you can get it.
"So for now it makes almost, like, no sense to do something that
has been tested for such a short period of time."
"For me, I will probably wait for now."
Not everyone at the Miami Open is as resistant to the idea of
getting the vaccine, Australian Open winner Naomi Osaka saying
she will get one when it is her turn.
"I'm planning on getting one," said Osaka. "For me, I feel like
whenever I'm eligible, I guess."
(Reporting by Steve Keating in Toronto; Editing by Kim Coghill)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
|